CDC Recommends Pfizer's RSV Vaccine for Pregnant Women to Protect Newborns

The U.S. Centers for Disease Control and Prevention (CDC) has recommended Pfizer's Abrysvo vaccine for respiratory syncytial virus (RSV) be given during pregnancy to provide additional protection for newborns against the disease. The CDC advisory panel voted 11-1 in favor of the recommendation, which was formally adopted by CDC Director Dr. Mandy Cohen. RSV is the leading cause of hospitalization among infants, and the vaccine is intended to be administered during weeks 32 to 36 of pregnancy. This recommendation follows the approval of nirsevimab, an RSV antibody injection, for infants and young children earlier this summer.